The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs

mBio. 2023 Aug 31;14(4):e0111623. doi: 10.1128/mbio.01116-23. Epub 2023 Aug 2.

Abstract

Combination antiretroviral therapy (cART) suppresses viral replication but does not cure HIV infection because a reservoir of infectious (intact) HIV proviruses persists in long-lived CD4+T cells. However, a large majority (>95%) of HIV-infected cells that persist on effective cART carry defective (non-infectious) proviruses. Defective proviruses consisting of only a single LTR (solo long terminal repeat) are commonly found as endogenous retroviruses in many animal species, but the frequency of solo-LTR HIV proviruses has not been well defined. Here we show that, in five pediatric donors whose viremia was suppressed on cART for at least 5 years, the proviruses in the nine largest clones of HIV-infected cells were solo LTRs. The sizes of five of these clones were assayed longitudinally by integration site-specific quantitative PCR. Minor waxing and waning of the clones was observed, suggesting that these clones are generally stable over time. Our findings show that solo LTRs comprise a large fraction of the proviruses in infected cell clones that persist in children on long-term cART. IMPORTANCE This work highlights that severely deleted HIV-1 proviruses comprise a significant proportion of the proviral landscape and are often overlooked.

Keywords: HIV; HIV cell clones; proviral quantification; provirus; solo LTR.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antiretroviral Therapy, Highly Active
  • CD4-Positive T-Lymphocytes
  • Clone Cells
  • HIV Infections* / drug therapy
  • HIV Long Terminal Repeat
  • HIV Seropositivity*
  • HIV-1* / genetics
  • Proviruses / genetics